b'I N T R O D U C T I O NMolecularDiagnostics TestsSomatic mutations play an increasingly important role in the risk stratification and managementof leukemia and lymphoma patients. Traditionally, classification and risk stratification have relied on cytogenetic studies; however, molecular detection of gene mutations and gene rearrangements are now central in the classification, risk stratification, and management of lymphoproliferative diseases. Molecular testing also complements cytogenetic testing results, which helps further refine stratification and prognosis, especially within specific disease subgroups.All of LabPMMs molecular tests conform to the Standard of Care as defined by the World Health Organization (WHO) and are recommended by members of the National Comprehensive Cancer Network, LeukemiaNet, and other world opinion leaders in hematology. LabPMM Services Catalog 2021|19'